FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.
You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.
Other companies in FibroGen’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).
FibroGen has a consensus price target of $10.00.
The stock price for FibroGen (NASDAQ: FGEN) is $0.5724 last updated January 17, 2025 at 7:59 PM EST.
There are no upcoming dividends for FibroGen.
FibroGen’s Q4 earnings are confirmed for Monday, February 24, 2025.
There is no upcoming split for FibroGen.
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.